Table 3.
Number of isolates with varying susceptibility profiles stratified by source.
| Susceptibility profile | Week 2 | Week 3 | Week 5 | Week 6 | Total | ||||
|---|---|---|---|---|---|---|---|---|---|
| Resistant | Intermediate | Litter | Faeces | Litter | Litter | Faeces | Carcass rinsate | Wastewater | |
| CXM | FOX | 3 | 7 | 3 | 16 | 17 | 1 | 47 | |
| CXM | FOX-CHL | 1 | 2 | 1 | 4 | ||||
| CXM | FOX-NIT | 1 | 1 | 5 | 9 | 16 | |||
| CXM | FOX-NIT-CHL | 1 | 1 | ||||||
| CXM | FOX-NIT-NA | 1 | 1 | ||||||
| AZM | CXM-FOX-CHL | 2 | 2 | ||||||
| AZM | CXM-FOX-NIT-CHL | 1 | 1 | ||||||
| PEF | CXM-FOX-CHL | 1 | 1 | ||||||
| PEF | CXM-FOX-NIT-CHL | 1 | 1 | ||||||
| CXM-FOX | — | 1 | 1 | 2 | |||||
| CXM-FOX | NIT | 2 | 2 | ||||||
| CXM-CHL | FOX | 1 | 1 | ||||||
| CXM-AZM | FOX-CHL | 1 | 3 | 4 | |||||
| CXM-AZM | FOX-NIT-CHL | 1 | 1 | ||||||
| CXM-PEF | FOX-CHL | 3 | 3 | ||||||
| CXM-PEF | FOX-CCHL-AMX | 1 | 1 | ||||||
| CXM-PEF | FOX-CHL-NA | 2 | 2 | ||||||
| CXM-PEF | FOX-CHL-NA-AMX | 1 | 1 | ||||||
| CXM-NIT | FOX-CHL | 1 | 1 | ||||||
| PEF-AZM | CXM-FOX-CHL | 4 | 4 | ||||||
| PEF-AZM | CXM-FOX-CHL-NA | 2 | 2 | ||||||
| PEF-AZM | CXM-FOX-NIT-CHL | 1 | 1 | ||||||
| CXM-PEF-AZM | FOX-CHL | 2 | 2 | ||||||
| CXM-PEF-AZM | FOX-NIT-CHL | 1 | 1 | 2 | |||||
| CXM-PEF-AZM | FOX-NIT-CHL-NA-AMX | 1 | 1 | ||||||
| CXM-CHL-PEF-AZM | FOX-NA | 1 | 1 | 1 | 3 | ||||
| — | CXM | 2 | 2 | ||||||
| — | CXM-NIT | 1 | 1 | ||||||
| — | CXM-FOX | 12 | 2 | 8 | 5 | 2 | 5 | 34 | |
| — | CXM-FOX-CHL | 3 | 3 | ||||||
| — | CXM-FOX-NIT | 10 | 10 | ||||||
| — | CXM-FOX-NIT-CHL | 1 | 1 | ||||||
| Susceptible | 21 | 31 | 52 | ||||||
| Total | 30 | 30 | 30 | 30 | 30 | 29 | 31 | 210 | |
CXM: cefuroxime; FOX: cefoxitin; CHL: chloramphenicol; NIT: nitrofurantoin; AZM: azithromycin; PEF: pefloxacin.